A recent poll reveals most US adults are hesitant about fall COVID-19 vaccinations, highlighting confusion over federal policies and declining trust in health agencies.

William Schaffner, MD, a veteran infectious disease expert and public health thought leader is concerned that rapidly shifting federal policy could impact future options.

Fewer than 1 in 5 eligible older adults in the US received the RSV vaccine during the first 2 seasons it was available, and uptake was lower based on SDOH.

The US FDA approved brensocatib as the first treatment for non–cystic fibrosis bronchiectasis.

RDX-002, an investigational, first-in-class therapeutic, significantly reduced weight regain after cessation of antiobesity treatment with semaglutide and tirzepatide.

The 9 influenza vaccines available for the upcoming respiratory virus season come from 4 manufacturers in single-dose syringes and vials and multidose vials may still be available.

Family physician Sarah Sams, MD, shares how to improve pediatric vaccine coadministration using pre‑visit planning and staff coordination.

Rural, low-income US counties with persistently low cervical cancer screening have almost twice the incidence and mortality compared with high-screening counties.

Jonathan Bonnet, MD, MPH, board certified in lifestyle and obesity medicine, explains how the 6 pillars of the former are essential to success in the latter.

Danish adults aged 65 and older at high-risk for serious infection with SARS-CoV-2 showed no increased risk of 29 serious adverse events following vaccination.

Your daily dose of the clinical news you may have missed.

Obesity medicine expert Bonnet answers questions about the downsides of GLP-1 therapy for obesity management and how lifestyle medicine interventions will help.

Schaffner describes the mood among his colleagues in infectious disease right now as anxious, perplexed, distressed, and angry. They expect the disruptions and their feelings to continue.

Effective pediatric vaccine conversations require trust and facts. Family physician Sarah Sams, MD, offers tips for addressing concerns without harming patient relationships.

The FDA Fast Track designation for NRX-100 (IV, preservative-free ketamine) expands by 10-fold the potential treatment population that seriously considers suicide.

A new study reveals that noninvasive LVEDP screening can enhance heart failure detection and improve patient outcomes in primary care settings.

Your daily dose of the clinical news you may have missed.

From EMR reports to targeted nurse visits, Sarah Sams, MD, outlines practical ways PCPs can catch up pediatric vaccinations before school starts.

Insulin delivered via nasal spray in this first-in-human PET imaging study was observed in 11 key brain areas relevant to cognitive decline, validating a new research avenue.

FDA accepts priority review of gepotidacin for uncomplicated urogenital gonorrhea, with phase 3 data showing non-inferiority to standard injectable therapy.

The oral peptide that selectively targets IL-23 offers a novel approach to quelling the inflammatory process that underlies plaque psoriasis.

Your daily dose of the clinical news you may have missed.

The obesity and lifestyle medicine specialist says while research on the question continues, a focus on optimizing nutritional health during treatment is essential.

Health information permeates social media platforms exposing Americans to advice, even when they don't want it. The good news? Not many trust it!

Board-certified family physician Sarah Sams, MD, urges physicians to actively engage their communities to build vaccine confidence and combat misinformation.